In Parkinson's disease Ronirol 0.5 Tablet helps relieve symptoms of Parkinson's disease such as tremors, muscle stiffness, and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in the coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner. In Restless leg syndrome Restless leg syndrome is a condition that causes an uncontrollable urge to move your legs, usually because of an uncomfortable sensation. It typically happens in the evening or nighttime hours when you're sitting or lying down. Moving or walking, that is change in posture, will control the unpleasant feeling temporarily. Ronirol 0.5 Tablet helps to relieve this uncomfortable urge and calms these sensations. Take it as advised by the doctor to get the maximum relief.
Caution is advised when consuming alcohol with Ronirol 0.5 Tablet. Please consult your doctor.
Ronirol 0.5 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ronirol 0.5 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Ronirol 0.5 Tablet suppresses serum prolactin and may interfere with breastfeeding.
Ronirol 0.5 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Ronirol 0.5 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Ronirol 0.5 Tablet may be needed. Please consult your doctor.
Ronirol 0.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Ronirol 0.5 Tablet may be needed. Please consult your doctor. Use of Ronirol 0.5 Tablet is not recommended in patients with the severe liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Icon Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: D D Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: East West Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ikon Pharmachem Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Davaindia Generic Pharmacy || ₹14.5/tablet (25% cheaper)